300206 Stock Overview
Edan Instruments, Inc. engages in the research, development, manufacture, and sale of medical equipment worldwide.
Edan Instruments, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥13.50|
|52 Week High||CN¥15.80|
|52 Week Low||CN¥8.30|
|1 Month Change||8.09%|
|3 Month Change||15.19%|
|1 Year Change||5.97%|
|3 Year Change||88.29%|
|5 Year Change||59.76%|
|Change since IPO||118.77%|
Recent News & Updates
|300206||CN Medical Equipment||CN Market|
Return vs Industry: 300206 exceeded the CN Medical Equipment industry which returned -13.2% over the past year.
Return vs Market: 300206 exceeded the CN Market which returned -16.9% over the past year.
|300206 Average Weekly Movement||9.7%|
|Medical Equipment Industry Average Movement||7.8%|
|Market Average Movement||5.8%|
|10% most volatile stocks in CN Market||9.0%|
|10% least volatile stocks in CN Market||3.8%|
Stable Share Price: 300206 is more volatile than 90% of CN stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: 300206's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Edan Instruments, Inc. engages in the research, development, manufacture, and sale of medical equipment worldwide. The company offers diagnostic electrocardiograph (ECG) products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as vital signs, transport, and central monitoring systems, as well as high acuity cares, acute and sub-acute cares, telemetry, and pulse oximetry products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic doppler systems, and video colposcopes. It also provides ultrasound imaging systems that include color doppler ultrasound and B/W digital ultrasound systems; and in-vitro diagnostics, which comprise hematology analyzers.
Edan Instruments, Inc. Fundamentals Summary
|300206 fundamental statistics|
Is 300206 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|300206 income statement (TTM)|
|Cost of Revenue||CN¥718.74m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.29|
|Net Profit Margin||10.55%|
How did 300206 perform over the long term?See historical performance and comparison